Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Postural orthostatic tachycardia syndrome

Postural orthostatic tachycardia syndrome

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Postural orthostatic tachycardia syndrome

7 trials tracked for Postural orthostatic tachycardia syndrome: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 105 citations.

7Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 3 Other / NA 3
  1. Phase 3 Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome Completed · 105 cited
  2. Phase 2 The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome Completed
  3. Phase 2 Using Mirabegron to Increase BP in Patients With POTS Completed
  4. Phase 2 Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS Completed
  5. N/A Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome Completed
  6. N/A Dietary Salt in Postural Tachycardia Syndrome Completed
Show 1 more trials
  1. N/A Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS) Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Symptom-informed updates increase predicted probabilities of hEDS and POTS in comorbid patients
Rheumatology Meta-analysis
Symptom-informed updates increase predicted probabilities of hEDS and POTS in comorbid patients New data reveals links between hEDS, POTS, and MCAS conditions
This meta-analysis synthesizes aggregate prevalence data to determine comorbidity probabilities among patients with hEDS, POTS, and MCAS. Th…
New research highlights how symptoms can help predict overlapping conditions like hEDS, POTS, and Mast Cell Activation Syndrome.
medRxiv Jul 29, 2026
Guideline proposes mechanistic phenotyping to distinguish POTS from autonomic failure
Cardiology Guideline
Guideline proposes mechanistic phenotyping to distinguish POTS from autonomic failure The POTS Label May Be Hiding What Actually Makes Patients Sick
A hypothesis-driven review and guideline for patients with POTS proposes reframing physiology by distinguishing compensatory orthostatic tac…
Calling POTS "dysautonomia" may push doctors to silence a symptom instead of fixing what triggered it.
Frontiers Apr 13, 2026